Sterile Otic Formulation for Single-Dose Ear Infection Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for fungal ear infections, such as otitis externa, require multiple applications, are often ineffective against a broad spectrum of pathogens, and may lead to recurrence due to incomplete delivery and potential toxicity, with a need for a single-dose, sterilized, and stable formulation that can effectively treat both fungal and bacterial infections along with inflammation.
Innovation Solution
A sterile formulation comprising a combination of antibacterial, antifungal, and anti-inflammatory agents in a thickened base that remains in the ear canal for an extended period, allowing continuous release of active ingredients, using heat sterilization and ionizing radiation to ensure stability and efficacy, and is designed to be administered once to achieve high cure rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple applications of treatment are required, then the treatment can be adjusted based on patient response, but treatment duration and patient inconvenience increase
Solution Approach 1:
The patent applies preliminary action by incorporating a sustained-release mechanism into the otic formulation that pre-provides medication over an extended period (at least 7 days). The formulation is designed to release active ingredients continuously, eliminating the need for multiple patient applications while maintaining treatment efficacy. This resolves the contradiction by providing long-lasting therapeutic effect through a single initial application.
2Ease of operation
If liquid form drugs are used, then administration is simple, but the drugs egress rapidly from the ear canal and cannot reach all infected areas
Solution Approach 1:
The patent applies parameter changes by modifying the physical state of the medication from liquid to a semi-solid or controlled-release formulation. This change in physical parameters allows the medication to remain in the ear canal for extended periods, reach all infected areas including upper regions, while still maintaining ease of administration through simple instillation.
3Duration of action of stationary object
If creams and ointments are used, then they remain in the ear longer, but they must be removed by the ENT physician
Solution Approach 1:
The patent applies the disposable principle by creating a formulation that is designed to be left in the ear canal without removal. The sustained-release mechanism allows the medication to complete its therapeutic action and then naturally dissipate or be cleared by normal ear canal functions, eliminating the need for physician removal while maintaining extended residence time for therapeutic effect.
4Reliability
If broad-spectrum antibiotics are used, then bacterial infections are treated, but fungal infections may develop or worsen
Solution Approach 1:
The patent applies universality by formulating a combination product that contains both antibacterial and antifungal active ingredients. This multi-functional formulation simultaneously treats bacterial infections while preventing or treating fungal infections, eliminating the need to choose between treating one pathogen type or the other and preventing harmful side effects of broad-spectrum antibiotic use.
5Reliability
If sterilization is applied to ensure safety, then microbial contamination is prevented, but drug stability and efficacy may be compromised
Solution Approach 1:
The patent applies preliminary action by performing sterilization of individual components before final formulation assembly. This approach allows each ingredient to be sterilized separately under conditions optimized for that specific substance, then combined under sterile conditions to create the final product. This prevents microbial contamination while preserving the stability and efficacy of heat-sensitive or radiation-sensitive active ingredients.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation effectively eradicates fungal and bacterial infections with a single application, reducing the risk of recurrence and bacterial resistance, while maintaining hygiene within the ear canal and adhering to FDA sterilization standards, achieving a high cure rate with prolonged symptom relief.
Implementation Method 1
using heat sterilization and ionizing radiation to ensure stability and efficacy
Implementation Method 2
using heat sterilization and ionizing radiation to ensure stability and efficacy
Data Source
AI summary
The present disclosure describes a sterile formulation and method for treating an ear infection, especially otomycosis and otitis externa, by administering a one-time only treatment comprising an antibiotic, and antifungal, and an optional anti-inflammatory in a thick, otic carrier. In one embodiment, the sterilization comprises e-beam irradiating ingredients the formulation while heat-sterilizing other ingredients before combining under sterile condition.